Application 090141
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090141-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090141-001 | AB1 |
| A090141-002 | AB1 |
| A090141-003 | AB1 |
| A090141-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090141-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090141-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090141-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090141-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090141-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-003 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090141-004 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-002 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-003 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090141-004 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-003 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090141-004 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-002 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-003 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090141-004 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-003 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090141-004 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-003 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090141-004 | AB1 | 1 | 5bbf6a4d5a75… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A090141-001 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-002 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-003 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090141-004 | PC | 2019-03-26 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-001 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-002 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-003 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A090141-004 | PC | 2019-03-26 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-001 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-002 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-003 | PC | 2019-03-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A090141-004 | PC | 2019-03-26 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-001 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-002 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-003 | PC | 2019-03-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090141-004 | PC | 2019-03-26 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | c835a34a-9bae-4d88-b951-1b78ab92f388 | 2026-05-13 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Umedica Laboratories USA Inc. | 6caf3b55-9bf4-4355-9e25-8bf368943fdd | 2026-04-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | REMEDYREPACK INC. | 82dfea4c-9fe5-438a-917f-8f7d395ee8ca | 2026-04-23 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Accord Healthcare Inc. | eedf3ad9-7d40-496d-b1a9-6200010c18e1 | 2026-04-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Amneal Pharmaceuticals NY LLC | 90f38460-62ad-492e-a3da-403d5a5a5d86 | 2026-04-15 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 351e28ca-3ae6-e535-e063-6394a90a9fb7 | 2026-03-23 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | 88132351-7fee-47ef-8007-ef2777543299 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | HEC Pharm USA Inc. | a0f728b6-2cc6-cb65-e053-2a95a90ab142 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | 3ea7612b-b004-43ef-accc-34c8ec5146b8 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | fee8c2be-ccfa-4c66-abed-5e232ec762ae | 2026-02-27 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| N/A | TADALAFIL | Bostal LLC | 78509a43-a907-4359-9022-f38c4f765880 | 2026-02-04 | Warnings, Adverse reactions | TADALAFIL |
| TADALAFIL | TADALAFIL | A-S Medication Solutions | cd94158b-43fa-44fc-a858-0983770efa83 | 2026-02-02 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | 2121cd9b-a2c0-4f19-a33d-939c6fb3826d | 2026-01-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | AvKARE | b96ae7f1-7d4a-a211-e053-2995a90ab6e2 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceutical,Inc. | 48850075-ac57-abb7-e063-6394a90a7881 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals, Inc. | 48892acb-43bb-a4d8-e063-6394a90a5d61 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Upsher-Smith Laboratories, LLC | ae801b15-0462-44af-99a4-affe3eed899a | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | affacb88-4af3-4ce9-961b-7fc37b169e9a | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | f34e4747-28be-4ae5-ac9a-a825083b6a9b | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 7e236f83-14bf-4862-91fb-74d766aef6a9 | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 71205-418 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71610-353 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-354 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 76519-1225 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1226 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1227 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |